Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 8/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 4/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 6/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluparoxan SCHEMBL9570339 | 1.00 | SLC6A2 (0.38) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 | |
| Fluparoxan SCHEMBL7173629 | 1.00 | SLC6A2 (0.38) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 | |
| Fluparoxan SCHEMBL112164 | 1.00 | SLC6A2 (0.38) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 | |
| Fluparoxan SCHEMBL9482018 | 0.98 | HTR6 (0.38) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 | |
| Fluparoxan SCHEMBL122268 | 0.98 | HTR6 (0.38) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 | |
| Fluparoxan SCHEMBL9482026 | 0.98 | HTR6 (0.38) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 | |
| SCHEMBL10375117 | 0.82 | BRD4 (0.36) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL10579193 | 0.81 | BRD4 (0.36) | SLC6A2SLC6A4SLC6A3HTR6HTR2C | |
| SCHEMBL10376272 | 0.81 | CHRNB2 (0.34) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 | |
| SCHEMBL10375154 | 0.81 | CHRNB2 (0.34) | SLC6A2CHRNB2CHRNA4SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4706683-A2 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG (CH) | 2026-03-11 | — | — | EP | disclosed |
| US-20230277448-A1 | CHEWABLE FORMULATIONS | ELANCO TIERGESUNDHEIT AG (CH) | 2023-09-07 | — | — | US | disclosed |
| CN-116685327-A | Orphan nuclear receptor modulators for the treatment of pancreatitis, glioblastoma, sarcopenia and stroke | 埃默里大学 | 2023-09-01 | — | — | CN | disclosed |
| CN-116507327-A | Chewable formulations | 礼蓝动物保健有限公司 | 2023-07-28 | — | — | CN | disclosed |
| EP-4208155-A1 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG (CH) | 2023-07-12 | — | — | EP | disclosed |
| CN-115269876-A | Method, device and medium for extracting action relationship between chemical and protein | 苏州大学 | 2022-11-01 | — | — | CN | disclosed |
| WO-2022049149-A1 | CHEWABLE FORMULATIONS | ELANCO TIERGESUNDHEIT AG (CH) | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277448-A1 | CHEWABLE FORMULATIONS | SI, TAS2R39, TAS2R31 | SLC6A2 3849/4885CHRNB2 2145/4885CHRNA4 1625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.